| | Verschil (%) | Varia. 5d. | Vaira. 1 jan. | Varia. 1j. | Varia. 3j. | Kapi. (M$) |
 | SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED | -0.73% | -4.40% | 14.35% | 12.86% | --.--% | 832 |
| | | | | | | |
 | CSL LIMITED | 1.73% | -1.80% | 3.59% | 14.49% | -4.48% | 99 957 |
 | SAMSUNG BIOLOGICS CO.,LTD. | -0.74% | 0.38% | -2.19% | 8.66% | 62.22% | 46 475 |
 | BIOGEN INC. | -1.43% | 1.51% | 3.26% | 26.97% | 3.03% | 41 176 |
| WUXI BIOLOGICS (CAYMAN) INC. | -2.61% | -6.10% | 9.02% | -14.09% | 96.83% | 36 135 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | -5.05% | -5.61% | 13.06% | -5.98% | 66.64% | 23 543 |
| BIOMARIN PHARMACEUTICAL INC. | -2.19% | 5.89% | 10.83% | 33.12% | 34.62% | 21 317 |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. | -0.41% | -3.47% | 6.74% | -12.43% | --.--% | 18 157 |
 | UCB | -0.48% | -2.31% | 1.79% | -14.93% | -9.87% | 15 534 |
| WALVAX BIOTECHNOLOGY CO., LTD. | -1.05% | -0.64% | 0.47% | -16.22% | 43.09% | 9 569 |
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | -0.36% | -3.82% | -4.97% | 7.21% | 51.24% | 9 164 |
| INNOVENT BIOLOGICS, INC. | -5.35% | 4.06% | 26.72% | 29.82% | 41.50% | 8 784 |
 | GRIFOLS, S.A. | -1.68% | -0.25% | 11.33% | -23.19% | -60.43% | 7 914 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | -3.69% | -8.71% | -21.96% | -12.49% | 59.03% | 7 911 |
| CELLTRION HEALTHCARE CO., LTD. | -2.02% | 0.00% | 0.17% | -3.32% | 12.26% | 7 621 |
 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | -0.65% | 0.87% | 6.68% | 25.88% | 33.66% | 6 601 |
| | | | | | | |
| | Gemiddelde | -1.73% | -1.33% | 4.30% | 2.90% | 30.67% | |
| | Gewogen gemiddelde per kap. | -0.88% | -1.38% | 4.34% | 7.21% | 28.60% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
